US
Signal: Blended — a blend of the available signals — business type and how their prices have moved together. Compare other signals →
| # | Ticker | Company | Sector / industry | Similarity | Tracked tipster calls |
|---|---|---|---|---|---|
| 1 | AMGN | Amgen Inc | Health Care · Biopharmaceuticals | 68 | no tracked calls |
| 2 | VRTX | Vertex Pharmaceuticals Inc | Health Care · Biopharmaceutical Development & Manufacturing | 59 | no tracked calls |
| 3 | GILD | Gilead Sciences Inc | Health Care · Pharmaceutical & Biotech | 57 | no tracked calls |
| 4 | ABBV | AbbVie Inc | Health Care · Pharmaceutical Manufacturing | 50 | no tracked calls |
| 5 | PFE | Pfizer Inc | Health Care · Drug Manufacturers - General | 49 | no tracked calls |
| 6 | MRK | Merck & Company Inc | Health Care · Pharmaceutical Manufacturing | 48 | no tracked calls |
| 7 | BMY | Bristol-Myers Squibb Company | Health Care · Pharmaceuticals | 48 | no tracked calls |
| 8 | LLY | Eli Lilly and Company | Health Care · Pharmaceuticals | 47 | 1 call · 1 source view |
| 9 | MDT | Medtronic PLC | Health Care · Medical Device Manufacturers | 33 | no tracked calls |
| 10 | DHR | Danaher Corporation | Industrials · Diversified Conglomerate | 32 | no tracked calls |
| 11 | TMO | Thermo Fisher Scientific Inc | Health Care · Laboratory Equipment & Supplies | 31 | no tracked calls |
| 12 | TFC | Truist Financial Corp | Financials · Commercial Banks | 31 | no tracked calls |
Similarity is a 0–100 index of a blend of the available signals — business type and how their prices have moved together (higher = more alike). The Tracked tipster calls column shows how many tracked public calls each peer has, from how many sources, and the best 90-day alpha among them — historical, measured outcomes (click a ticker to see who called it). How this is computed.
Hypothetical, paper-traded outcomes — entries are simulated at the first market bar after a call was detected; no real capital is at risk. Past performance is no guarantee of future results. This is general information about share characteristics, not a recommendation to buy, sell, or switch between any securities.
No tracked calls yet.